A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony sti (Q47899404)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2002

Language	Label	Description	Also known as
English	A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony sti	scientific article published in April 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony sti (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

0 references

Plasmodium falciparum

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Stephen L. Hoffman

14

object named as

Stephen L Hoffman

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

Francois Villinger

2

object named as

Francois Villinger

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

author name string

Sanjai Kumar

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

Miranda Oakley

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

Joao C Aguiar

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

Trevor R Jones

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

Richard C Hedstrom

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

Kalpana Gowda

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

John Chute

8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

Anthony Stowers

9

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

David C Kaslow

10

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

Elaine K Thomas

11

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

John Tine

12

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

Dennis Klinman

13

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

Walter W Weiss

15

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

immunology Letters

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

81

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

13-24

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization against blood-stage rodent malaria using purified parasite antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization against malaria with a recombinant protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

An OspA-Based DNA Vaccine Protects Mice against Infection with Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP1(19)) variants secreted from Saccharomyces cerevisiae.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sterile protection of monkeys against malaria after administration of interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of the precursor of the major merozoite surface antigens during the hepatic stage of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900316-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0165-2478(01)00316-9

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/11841841

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47899404&oldid=1401044271"